Putting US First; Fueling Operation Warp Speed!

Today, President Trump is taking further action under the Defense Production Act to end America’s overreliance on foreign supply chains. The Administration has used the Defense Production Act more than 30 times to date, helping to secure critical supplies of ventilators, personal protective equipment, testing supplies, pharmaceutical products, and more during the global Coronavirus pandemic. Now, the Administration is providing a $765 million loan to Kodak to support the launch of Kodak Pharmaceuticals, which will boost America’s domestic production of much-needed drugs. Once fully operational, Kodak Pharmaceuticals will manufacture up to 25 percent of active pharmaceutical ingredients for certain generic medicines. “This is not about China or India or any one country,” White House Director of Trade and Manufacturing Policy Peter Navarro says. “It’s about America losing its pharmaceutical supply chains to the sweat shops, pollution havens, and tax havens around the world that cheat America out of its pharmaceutical independence.” MORE: Kodak Shifts Into Drug Production With Help of U.S. Loan

Several Coronavirus vaccines reach late-stage trials Operation Warp Speed, one of President Trump’s most important responses to the Coronavirus, is a historic partnership between the federal government, scientific community, and private sector to develop a safe COVID-19 vaccine in record time. Its goal is to produce 300 million doses of vaccine and have initial doses ready by January. The once-in-a-generation effort is already achieving incredible results. Clinical trials are showing promising early data, and manufacturing is already ramping up in preparation. Several vaccine candidates, including ones from AstraZeneca, Moderna, and Pfizer, are either in or about to begin late-stage trials. Yesterday, President Trump toured a Fujifilm Diosynth Biotechnologies plant in North Carolina, where he gave reporters an update about progress toward a vaccine. “Not only is Operation Warp Speed accelerating the development of a vaccine—we’re also directing a colossal industrial mobilization to ensure its rapid delivery,” he said. “Nothing has happened like this since the end of World War II.” Rather than rely on government command-and-control schemes to fight the Coronavirus, the Trump Administration is marshalling America’s scientific genius across the public, private, and nonprofit sectors. The FDA has authorized more than 185 tests under emergency authorities, including at least 30 antibody tests. As a result of all these efforts, a number of promising therapies for the Coronavirus, such as Remdesivir, have been identified and are already in use. 🎬 “The United States has now conducted more than 51 million tests” LEARN MORE: A once-in-a-generation effort to develop a vaccine

Photo of the Day

President Trump tours the Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies | July 27, 2020